The New bacteriophage HY9001BP having bacteriolysis ability against Salmonella enterica serovar Enteritidis and products containing thereof as effective component

摘要

PURPOSE: A novel bacteriophage HY9001BP is provided to ensure Salmonella enteritidis-specific apoptotic ability and to be used as a pharmaceutical composition, feed additive, and disinfectant for preventing and treating salmonellosis. CONSTITUTION: A bacteriophage HY9001BP(deposit number: KCTC11847BP) has Salmonella Enteritidis-specific apoptotic ability. The bacteriophage has a genome of sequence numbers 1-5. A pharmaceutical composition for diseases caused by Salmonella Enteritidis contains the bacteriophage as an active ingredient. The diseases include food poisoning, enteritis, salmonellosis, fowl typhoid, or acute bacillemia. A feed additive contains the bacteriophage as an active ingredient. A disinfectant contains the bacteriophage as an active ingredient.